Study of Muscadine Grape Extract (MGE) in Advanced Malignancy

What we are studying

The purpose of this research study is to find the highest dose of muscadine grape extract that can be given to people with cancer without causing severe side effects. Muscadine grape extract is a natural product that has potential anti-cancer properties but has not been FDA approved for use as a cancer therapy at any dose level.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Confirmed metastatic or unresectable cancer and have failed therapies
  • Willingness to signed consent
  • Stable supplement usage for 2 weeks or greater prior to starting study and continue while on study

What is involved

  • Surveys
  • Muscadine grape pills
  • Blood draw


Parking Validation for study visits

Contact Information

Study Coordinator
Patricia Smith

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.